Taken together, these clinical findings are consistent with our model in which stress accumulation during cancer progression was assumed to drive R-loop accumulation, which is further attenuated by RNASEH2A induction to prevent R-loop–mediated DNA damage and apoptosis. This evidence concerns the gene RNASEH2A and cancer.